Enteral Feeding Devices Companies

Fresenius SE & Co. KGAA. (Germany) and Cardinal Health, Inc. (US) are Leading Players in the Enteral Feeding Devices Market

The global enteral feeding devices market is projected to reach USD 4.76 billion by 2032 from USD 3.27 billion in 2025, growing at a CAGR of 5.5% during the forecast period.

The key factors driving the growth of the enteral feeding devices market include the increasing prevalence of chronic diseases. Conditions like diabetes, cancer, and gastrointestinal disorders can significantly impair a patient's ability to eat orally. Enteral feeding devices provide a reliable and safe way to deliver essential nutrients to these patients, supporting recovery and improving quality of life. Growing demand for medical devices in geriatric care, along with greater affordability of medical procedures and devices, are also fueling market growth.

To know about the assumptions considered for the study download the pdf brochure

  • In February 2024, Fresenius SE & Co. KGaA (Germany) collaborated with the European Society for Intensive Care Medicine (ESICM). This partnership is founded on two important pillars: to support the educational efforts and professional growth of medical professionals, and to leave a lasting impact on the future of healthcare.
  • In September 2023, Cardinal Health (US) launched the Kangaroo OMNI, an enteral feeding pump equipped with advanced features for the customized needs of patients.

The prominent players in the enteral feeding devices market include Fresenius SE & Co. KGaA (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Danone S.A. (France), B. Braun Melsungen AG (US), Boston Scientific Corporation (US), Nestlé S.A. (Switzerland), Becton, Dickinson and Company (US), CONMED Corporation (US), Baxter International Inc. (US), Abbott (US), Moog, Inc. (US), Cook Medical (US), Terumo Corporation (Japan), Weigao Medical International Co., Ltd. (China), JMS Co., Ltd.(Japan), Vygon (France), Applied Medical Technology (US), Amsino International Inc. (US), and Medela AG (Switzerland).

Fresenius SE & Co. KGaA (Germany)

Fresenius Kabi is a leading player in the global enteral feeding devices market, mainly because of its integrated clinical nutrition ecosystem, which combines feeding devices, enteral formulas, and digital monitoring solutions. The company’s product range includes enteral pumps, gravity feeding sets, PEG and nasogastric tubes, and administration accessories, allowing it to provide comprehensive enteral nutrition support in hospitals and homecare settings. Its growth is fueled by ongoing R&D investments focused on safety and automation, exemplified by the Compat Ella and Flocare Infinity enteral feeding pump series that ensure precise dosing, portability, and dependability. Fresenius benefits from strong hospital partnerships and a significant presence in critical care nutrition, aligning with global trends toward home-based enteral feeding and personalized nutritional therapy. Additionally, the company’s strict adherence to ISO 80369-3 (ENFit) standards, along with its clinical education programs for healthcare professionals, enhances customer loyalty and brand trust. By leveraging its worldwide manufacturing network in Europe, Asia, and North America, Fresenius maintains a cost-effective, scalable production model, positioning itself as a leading supplier for both public and private healthcare systems.

Cardinal Health, Inc. (US)

Cardinal Health’s leadership in the enteral feeding market comes from its extensive and dependable product distribution network and its focus on safety, standardization, and clinical efficiency. The company’s enteral product line—particularly under the Monoject and Cardinal Health brands—includes ENFit-compatible syringes, enteral administration sets, and accessories designed for precision and infection control. A key factor in Cardinal Health’s growth is its strategic emphasis on disposable medical devices, providing hospitals with cost-effective and regulation-compliant solutions. Its extensive logistics and supply chain capabilities ensure continuous device availability even during high demand, making it a trusted partner for hospitals and long-term care facilities across North America and Europe. The company’s dedication to sustainability and supply reliability has also bolstered its presence in government and group purchasing organization (GPO) contracts. Moreover, Cardinal Health invests significantly in training programs for nursing and nutrition teams, improving product usability and compliance with homecare nutrition. Its excellent after-sales service, product quality assurance, and adherence to ISO and FDA standards position it as a preferred supplier, reinforcing its top-tier market standing.

Avanos Medical, Inc. (US)

Avanos Medical is known for pioneering safety-engineered, innovation-driven enteral feeding solutions that have transformed clinical practices worldwide. The company’s flagship Kangaroo brand leads the segment with enteral feeding pumps, tubes, and accessories recognized for their accuracy, simplicity, and patient comfort. Avanos’ focus on ISO 80369-3/ENFit standardization has established global benchmarks for preventing misconnections and enhancing patient safety. Its Kangaroo Joey and Kangaroo Connect pumps incorporate smart technology for flow monitoring, digital programming, and precise alarms, supporting use in both hospitals and homecare settings. The company’s growth is driven by a strong R&D emphasis on device safety, material biocompatibility, and sensor-based flow systems that address long-standing clinical challenges like tube blockage, dislodgement, and dosing inconsistencies. Avanos also advances through clinical partnerships and product training programs, facilitating smoother integration within multidisciplinary nutrition teams. Operating across the US, Europe, and APAC, Avanos utilizes lean manufacturing and a patient-focused innovation pipeline to deliver value across various healthcare environments, solidifying its leading position in the enteral device market.

Market Ranking

The enteral feeding devices market is highly competitive, dominated by major players such as Fresenius SE & Co. KGaA (Germany), Cardinal Health, Inc., Avanos Medical, Inc. (US), Danone S.A. (France), and B. Braun Melsungen AG (Germany), which hold the largest market share. These leading companies have strong global networks and established distribution channels in regions such as North America and Europe. They leverage partnerships, advanced R&D, and brand strength to sustain their dominance. Meanwhile, smaller competitors focus on offering low-cost products and innovative technologies, creating a market landscape that includes both dominant global firms and agile, regional providers.

Related Reports:

Enteral Feeding Devices Market by Type (Enteral Feeding Tubes, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding Tubes), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Global Forecast to 2032

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com

Enteral Feeding Devices Market Size,  Share & Growth Report
Report Code
MD 1289
RI Published ON
5/15/2025
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
X
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2025 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status